Hyangkyeong Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hyangkyeong Oh has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Eunjoo Kim
Department of Psychiatry, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
4 shared publications - Euno Kim
College of Nursing, Yonsei University, Seoul, Republic of Korea
2 shared publications - Hajae Jeon
Department of public health, Graduate School, Yonsei University, Seoul, Republic of Korea
2 shared publications - Jaeyong Shin
Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
2 shared publications - Junghan Lee
Department of Child and Adolescent Psychiatry, Severance Children’s Hospital, Yonsei University College of Medicine, Seoul, Korea
2 shared publications - Meelim Kim
Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, La Jolla, CA, United States
2 shared publications
Latest Publications
- Open Access
- 13 April 2026
- Published by Association for Computing Machinery (ACM)
- p. 1-23
Toward Flexible Psychiatric History-Taking and Visualization: Exploring Clinician Perspectives with Large Language Models
The initial psychiatric interview centers on patients’ chief complaints, symptoms, and functional impairments, forming the basis of diagnostic impressions. In real clinical practice, however, interviews are constrained by limited time and the unpredictability of patient responses, making it difficult to secure essential information efficiently. While prior conversational agents have focused on conversationalizing validated instruments or advancing interview systems in general medical domains, little research has addressed the distinctive challenges of initial psychiatric history-taking from clinicians’ perspective. We present a flexible psychiatric interviewer that dynamically adapts question flow and prioritizes clinically essential information within time constraints, with a clinical dashboard for efficient review. We evaluated the system through 1,440 simulated patient dialogues and follow-up interviews with 19 clinicians. Results show that it captures essential information within a limited time while preserving conversational flexibility and empathy, highlighting design implications for coachable and responsible AI interviewers that align with clinical practice.
- 13 April 2026
- Published by Association for Computing Machinery (ACM)
- p. 1-23
Open AccessToward Flexible Psychiatric History-Taking and Visualization: Exploring Clinician Perspectives with Large Language Models
The initial psychiatric interview centers on patients’ chief complaints, symptoms, and functional impairments, forming the basis of diagnostic impressions. In real clinical practice, however, interviews are constrained by limited time and the unpredictability of patient responses, making it difficult to secure essential information efficiently. While prior conversational agents have focused on conversationalizing validated instruments or advancing interview systems in general medical domains, little research has addressed the distinctive challenges of initial psychiatric history-taking from clinicians’ perspective. We present a flexible psychiatric interviewer that dynamically adapts question flow and prioritizes clinically essential information within time constraints, with a clinical dashboard for efficient review. We evaluated the system through 1,440 simulated patient dialogues and follow-up interviews with 19 clinicians. Results show that it captures essential information within a limited time while preserving conversational flexibility and empathy, highlighting design implications for coachable and responsible AI interviewers that align with clinical practice.
- Open Access
- 27 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Feasibility, Efficacy, and Predictors for Treatment Response in a Tailored Digital CBT-E Program for Binge Eating in Adolescents and Young Adults: A Pilot Randomized Controlled Trial With Multimodal Assessment (Preprint)
BACKGROUND Binge eating is a prevalent and clinically significant condition in adolescents and young adults, associated with functional impairment and increased risk of progression to full-syndrome eating disorders. Digital guided self-help programs based on enhanced cognitive behavioral therapy (CBT-E) have been proposed as scalable options for early intervention; however, implementing CBT-E’s individualized formulation in digital formats remains challenging. In addition, objective indicators of self-regulatory change underlying CBT-E effects are limited. OBJECTIVE This pilot randomized controlled trial evaluated the feasibility and preliminary outcomes of PlanEat, a developmentally and symptomatically tailored digital CBT-E–based guided self-help program. Using a multimodal assessment approach, we examined neurophysiological indicators of self-regulation and predictors of treatment response. METHODS Adolescents and young adults aged 13–22 years with recent binge-eating episodes were randomized to an immediate intervention group or a waitlist control group in a 2-arm waitlist-controlled crossover design. The intervention consisted of an 8-week mobile-based guided self-help CBT-E program with symptom-driven tailoring. Feasibility outcomes included attrition, adherence, engagement, and usability. Clinical outcomes were assessed using validated self-report measures of eating disorder psychopathology and functional impairment. Neurophysiological outcomes included functional near-infrared spectroscopy (fNIRS) during executive control tasks and heart rate variability (HRV) during a virtual reality–based social stress paradigm. Intervention effects during the active treatment period (T0–T1) were analyzed using linear mixed-effects models and covariance analysis. Hierarchical regression analyses explored whether adherence and baseline neurophysiological indicators predicted change in global Eating Disorder Examination Questionnaire (EDE-Q) scores. RESULTS Of 64 randomized participants, 46 were included in the primary clinical analyses. Feasibility criteria were met, with favorable overall usability ratings. The immediate intervention group showed a significantly greater reduction in global EDE-Q scores compared with the waitlist group (β = 0.66, SE = 0.28, P = .021). Improvements were also observed across eating-related outcomes, functional impairment, and self-esteem. Clinical benefits were largely maintained at 16-week follow-up, with additional reductions in anxiety symptoms. Exploratory neurophysiological analyses showed attenuated reductions in prefrontal activation during inhibitory control tasks in the intervention group and a significant Group × Time interaction in lnHF reactivity, indicating divergent autonomic stress regulation trajectories. In hierarchical regression models, greater adherence and lower baseline upper right prefrontal HbR activation were independently associated with larger reductions in global EDE-Q scores. CONCLUSIONS The PlanEat program showed acceptable feasibility and preliminary clinical benefits in adolescents and young adults with binge eating. Exploratory multimodal findings suggest that neurophysiological measures may complement behavioral indicators by providing objective indices of self-regulatory change and prognostic information. Together, these results support further evaluation of PlanEat in a fully powered randomized controlled trial and highlight the potential value of integrating multimodal markers to better characterize treatment response in digital CBT-E interventions. CLINICALTRIAL ClinicalTrials.gov Identifier: NCT05615090
- 27 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessFeasibility, Efficacy, and Predictors for Treatment Response in a Tailored Digital CBT-E Program for Binge Eating in Adolescents and Young Adults: A Pilot Randomized Controlled Trial With Multimodal Assessment (Preprint)
BACKGROUND Binge eating is a prevalent and clinically significant condition in adolescents and young adults, associated with functional impairment and increased risk of progression to full-syndrome eating disorders. Digital guided self-help programs based on enhanced cognitive behavioral therapy (CBT-E) have been proposed as scalable options for early intervention; however, implementing CBT-E’s individualized formulation in digital formats remains challenging. In addition, objective indicators of self-regulatory change underlying CBT-E effects are limited. OBJECTIVE This pilot randomized controlled trial evaluated the feasibility and preliminary outcomes of PlanEat, a developmentally and symptomatically tailored digital CBT-E–based guided self-help program. Using a multimodal assessment approach, we examined neurophysiological indicators of self-regulation and predictors of treatment response. METHODS Adolescents and young adults aged 13–22 years with recent binge-eating episodes were randomized to an immediate intervention group or a waitlist control group in a 2-arm waitlist-controlled crossover design. The intervention consisted of an 8-week mobile-based guided self-help CBT-E program with symptom-driven tailoring. Feasibility outcomes included attrition, adherence, engagement, and usability. Clinical outcomes were assessed using validated self-report measures of eating disorder psychopathology and functional impairment. Neurophysiological outcomes included functional near-infrared spectroscopy (fNIRS) during executive control tasks and heart rate variability (HRV) during a virtual reality–based social stress paradigm. Intervention effects during the active treatment period (T0–T1) were analyzed using linear mixed-effects models and covariance analysis. Hierarchical regression analyses explored whether adherence and baseline neurophysiological indicators predicted change in global Eating Disorder Examination Questionnaire (EDE-Q) scores. RESULTS Of 64 randomized participants, 46 were included in the primary clinical analyses. Feasibility criteria were met, with favorable overall usability ratings. The immediate intervention group showed a significantly greater reduction in global EDE-Q scores compared with the waitlist group (β = 0.66, SE = 0.28, P = .021). Improvements were also observed across eating-related outcomes, functional impairment, and self-esteem. Clinical benefits were largely maintained at 16-week follow-up, with additional reductions in anxiety symptoms. Exploratory neurophysiological analyses showed attenuated reductions in prefrontal activation during inhibitory control tasks in the intervention group and a significant Group × Time interaction in lnHF reactivity, indicating divergent autonomic stress regulation trajectories. In hierarchical regression models, greater adherence and lower baseline upper right prefrontal HbR activation were independently associated with larger reductions in global EDE-Q scores. CONCLUSIONS The PlanEat program showed acceptable feasibility and preliminary clinical benefits in adolescents and young adults with binge eating. Exploratory multimodal findings suggest that neurophysiological measures may complement behavioral indicators by providing objective indices of self-regulatory change and prognostic information. Together, these results support further evaluation of PlanEat in a fully powered randomized controlled trial and highlight the potential value of integrating multimodal markers to better characterize treatment response in digital CBT-E interventions. CLINICALTRIAL ClinicalTrials.gov Identifier: NCT05615090
- Open Access
- 24 December 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e69248
Developing and Evaluating Guidelines to Prevent Overdependence on Digital Therapeutics in Children and Adolescents: Randomized Controlled Trial
Background: Digital therapeutics (DTx) for children and adolescents with mental health problems have been developed in the health care industry. Despite reports of side effects from DTx for children and adolescents, there have been no guidelines to address the prevention of DTx overdependence among young users. Objective: This study aimed to identify the requirements for guidelines to prevent DTx overdependence in children and adolescents and to develop and evaluate these guidelines. Methods: We conducted 2 phases. This study first involved a phase I survey to develop guidelines, including assessments of smartphone usage and mental health conditions. The second phase evaluated the guidelines’ effectiveness, reliability, necessity, and satisfaction using a visual analog scale through a randomized controlled trial. Participants—45 children and adolescents aged 9-16 years and 42 caregivers—were randomly assigned to the experimental and control groups. Results: Phase I revealed that blocking mobile applications and notifications (mean 8.5, SD 1.8) and parental monitoring (mean 8.5, SD 2.1) were effective preventive features. Caregivers, children, and adolescents expressed concerns about the side effects and overdependence of DTx and decreased effects due to nonindividualized guidelines in subjective responses to the phase I survey. Based on these insights, personalized guidelines for phase II were developed, in which overall mean visual analog scale scores for guideline evaluation were higher in the experimental group, except for necessity among caregivers (mean 8.5, SD 1.3 versus mean 8.7, SD 1.2). Conclusions: Both caregivers and children and adolescents demonstrated the need for guidelines to prevent overdependence on DTx distinct from smartphone usage. Tailored guidelines may be acceptable for use in real-world therapeutic protocols. Guidelines to prevent overdependence on DTx in children and adolescents and to achieve a balance between their benefits and risks need to be established. Trial Registration: Clinical Research Information Service (CRiS) of the Republic of Korea KCT0008893; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=25609
- 24 December 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e69248
Open AccessDeveloping and Evaluating Guidelines to Prevent Overdependence on Digital Therapeutics in Children and Adolescents: Randomized Controlled Trial
Background: Digital therapeutics (DTx) for children and adolescents with mental health problems have been developed in the health care industry. Despite reports of side effects from DTx for children and adolescents, there have been no guidelines to address the prevention of DTx overdependence among young users. Objective: This study aimed to identify the requirements for guidelines to prevent DTx overdependence in children and adolescents and to develop and evaluate these guidelines. Methods: We conducted 2 phases. This study first involved a phase I survey to develop guidelines, including assessments of smartphone usage and mental health conditions. The second phase evaluated the guidelines’ effectiveness, reliability, necessity, and satisfaction using a visual analog scale through a randomized controlled trial. Participants—45 children and adolescents aged 9-16 years and 42 caregivers—were randomly assigned to the experimental and control groups. Results: Phase I revealed that blocking mobile applications and notifications (mean 8.5, SD 1.8) and parental monitoring (mean 8.5, SD 2.1) were effective preventive features. Caregivers, children, and adolescents expressed concerns about the side effects and overdependence of DTx and decreased effects due to nonindividualized guidelines in subjective responses to the phase I survey. Based on these insights, personalized guidelines for phase II were developed, in which overall mean visual analog scale scores for guideline evaluation were higher in the experimental group, except for necessity among caregivers (mean 8.5, SD 1.3 versus mean 8.7, SD 1.2). Conclusions: Both caregivers and children and adolescents demonstrated the need for guidelines to prevent overdependence on DTx distinct from smartphone usage. Tailored guidelines may be acceptable for use in real-world therapeutic protocols. Guidelines to prevent overdependence on DTx in children and adolescents and to achieve a balance between their benefits and risks need to be established. Trial Registration: Clinical Research Information Service (CRiS) of the Republic of Korea KCT0008893; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=25609
- Open Access
- 25 November 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Developing and Evaluating Guidelines to Prevent Overdependence on Digital Therapeutics in Children and Adolescents: Randomized Controlled Trial (Preprint)
BACKGROUND Digital therapeutics (DTx) for children and adolescents with mental health problems have been developed in the health care industry. Despite reports of side effects from DTx for children and adolescents, there have been no guidelines to address the prevention of DTx overdependence among young users. OBJECTIVE This study aimed to identify the requirements for guidelines to prevent DTx overdependence in children and adolescents and to develop and evaluate these guidelines. METHODS We conducted 2 phases. This study first involved a phase I survey to develop guidelines, including assessments of smartphone usage and mental health conditions. The second phase evaluated the guidelines’ effectiveness, reliability, necessity, and satisfaction using a visual analog scale through a randomized controlled trial. Participants—45 children and adolescents aged 9-16 years and 42 caregivers—were randomly assigned to the experimental and control groups. RESULTS Phase I revealed that blocking mobile applications and notifications (mean 8.5, SD 1.8) and parental monitoring (mean 8.5, SD 2.1) were effective preventive features. Caregivers, children, and adolescents expressed concerns about the side effects and overdependence of DTx and decreased effects due to nonindividualized guidelines in subjective responses to the phase I survey. Based on these insights, personalized guidelines for phase II were developed, in which overall mean visual analog scale scores for guideline evaluation were higher in the experimental group, except for necessity among caregivers (mean 8.5, SD 1.3 versus mean 8.7, SD 1.2). CONCLUSIONS Both caregivers and children and adolescents demonstrated the need for guidelines to prevent overdependence on DTx distinct from smartphone usage. Tailored guidelines may be acceptable for use in real-world therapeutic protocols. Guidelines to prevent overdependence on DTx in children and adolescents and to achieve a balance between their benefits and risks need to be established. CLINICALTRIAL Clinical Research Information Service (CRiS) of the Republic of Korea KCT0008893; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=25609
- 25 November 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDeveloping and Evaluating Guidelines to Prevent Overdependence on Digital Therapeutics in Children and Adolescents: Randomized Controlled Trial (Preprint)
BACKGROUND Digital therapeutics (DTx) for children and adolescents with mental health problems have been developed in the health care industry. Despite reports of side effects from DTx for children and adolescents, there have been no guidelines to address the prevention of DTx overdependence among young users. OBJECTIVE This study aimed to identify the requirements for guidelines to prevent DTx overdependence in children and adolescents and to develop and evaluate these guidelines. METHODS We conducted 2 phases. This study first involved a phase I survey to develop guidelines, including assessments of smartphone usage and mental health conditions. The second phase evaluated the guidelines’ effectiveness, reliability, necessity, and satisfaction using a visual analog scale through a randomized controlled trial. Participants—45 children and adolescents aged 9-16 years and 42 caregivers—were randomly assigned to the experimental and control groups. RESULTS Phase I revealed that blocking mobile applications and notifications (mean 8.5, SD 1.8) and parental monitoring (mean 8.5, SD 2.1) were effective preventive features. Caregivers, children, and adolescents expressed concerns about the side effects and overdependence of DTx and decreased effects due to nonindividualized guidelines in subjective responses to the phase I survey. Based on these insights, personalized guidelines for phase II were developed, in which overall mean visual analog scale scores for guideline evaluation were higher in the experimental group, except for necessity among caregivers (mean 8.5, SD 1.3 versus mean 8.7, SD 1.2). CONCLUSIONS Both caregivers and children and adolescents demonstrated the need for guidelines to prevent overdependence on DTx distinct from smartphone usage. Tailored guidelines may be acceptable for use in real-world therapeutic protocols. Guidelines to prevent overdependence on DTx in children and adolescents and to achieve a balance between their benefits and risks need to be established. CLINICALTRIAL Clinical Research Information Service (CRiS) of the Republic of Korea KCT0008893; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=25609